Form 4: Medicine Man Technologies Officer Acquires Shares Through Performance Stock Units

Daniel Pabon, Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, acquired 15,170 shares of common stock on May 3, 2024, through the vesting of performance stock units.

Summary

• On May 3, 2024, Daniel Pabon, Chief Policy and Regulatory Affairs Officer of Medicine Man Technologies, Inc. (SHWZ), acquired 15,170 shares of common stock.
• The acquisition was a result of performance stock units (PSUs) granted on May 3, 2023, vesting.
• Each PSU represented a contingent right to receive shares of common stock based on the achievement of performance metrics.
• The reported transaction increased Pabon's direct ownership to 15,320 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition through vested performance units. The vesting suggests performance goals were met, which is mildly positive.

Positives

• The vesting of performance stock units indicates that performance metrics were met, which could be seen as a positive sign for the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. This filing indicates a transaction by a key officer at Medicine Man Technologies.

Stakeholder Impact

• The acquisition of shares by a company officer could be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates

Keywords

Medicine Man Technologies, SHWZ, Daniel Pabon, Form 4, Performance Stock Units, PSU, Beneficial Ownership, Officer, Shares, Vesting